Bibliografija osebe. Seznam zajema vsa gradiva in ne le tista, kje je oseba mentor.

Doktorska dela (1)

1. Vida Kocbek: Preučevanje možnih bioloških označevalcev pri ovarijski endometriozi

Diplomska dela (9)

1. Alenka Žumer: Analiza nekaterih možnih reakcijskih mehanizmov 17[beta]-hidroksisteroid dehidrogenaze iz nitaste glive Cochliobolus lunatus
2. Maja Medar: Ugotavljanje prisotnosti proteinov CYP1B1 in COMT pri raku endometrija
3. Polona Božnar: Uporaba suzukijeve reakcije za pripravo derivatov indola in kumarina kot potencialnih inhibitorjev 17ß-hidroksisteroid-dehidrogenaze tipa 1
4. Nejc Berčič: Sinteza kumarinskih derivatov kot potencialnih inhibitorjev encima 17ß-hidroksisteroid-dehidrogenaze tipa 1
5. Maša Sinreih: Novi derivati antranilne kisline kot inhibitorji aldo/keto-reduktaz z AKR1C1-AKRC1C3
6. Aleš Šket: Ugotavljanje prisotnosti proteinov AKR1B1 in AKR1B10 pri raku endometrija
7. Marjeta Česen: Derivati 2-fenilcimetne kisline kot inhibitorji človeških hidroksiteroid-dehidrogenaz AKR1C1 in AKR1C3
8. Gregor Bajc: Študije izražanja 17[beta]-hidroksisteroid-dehidrogenaze AKR1C3 pri raku endometrija
9. Eva Lozič: Študije izražanja estrogenskih in progesteronskih receptorjev pri raku endometrija

Druga dela (22)

1. Marija Gjorgoska, Tea Lanišnik-Rižner: Estrogens and the Schrödinger's cat in the ovarian tumor microenvironment
2. Eva Lozič: Študije izražanja estrogenskih in progesteronskih receptorjev pri raku endometrija
3. Marija Gjorgoska, Tea Lanišnik-Rižner: Integration of androgen hormones in endometrial cancer biology
4. Renata Pavlič, Marija Gjorgoska, Tea Lanišnik-Rižner: Model cell lines and tissues of different HGSOC subtypes differ in local estrogen biosynthesis
5. Stefan Poschner, Judith Wackerlig, Dan Cacsire Castillo-Tong, Andrea Wolf, Isabel von der Decken, Tea Lanišnik-Rižner, Renata Pavlič, Anastasia Meshcheryakova, Diana Mechtcheriakova, Monika Fritzer-Szekeres, Theresia Thalhammer, Walter Jäger: Metabolism of estrogens
6. Renata Pavlič, Suzana Vidic, Maja Anko, Tamara Knific, Tomaž Büdefeld, Kristina Marton, Maša Sinreih, Stefan Poschner, Walter Jäger, Snježana Frković-Grazio, Tea Lanišnik-Rižner: Altered profile of E1-S transporters in endometrial cancer
7. Maša Sinreih, Rebeka Jójárt, Zoltán Kele, Tomaž Büdefeld, Gábor Paragi, Erzsébet Mernyák, Tea Lanišnik-Rižner: Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
8. Luka Roškar, Teja Klančič, Tamara Knific, Tea Lanišnik-Rižner, Špela Smrkolj: Tie-2, G-CSF, and leptin as promising diagnostic biomarkers for endometrial cancer
9. Jean-Philippe Emond, Patrick Caron, Maja Pušić Novak, Véronique Turcotte, David Simonyan, Andrej Vogler, Joško Osredkar, Tea Lanišnik-Rižner, Chantal Guillemette: Circulating estradiol and its biologically active metabolites in endometriosis and in relation to pain symptoms
10. Maja Pušić Novak, Teja Klančič, Tamara Knific, Andrej Vogler, Ronny Schmidt, Christoph Schröder, Tea Lanišnik-Rižner: Antibody arrays identified cycle-dependent plasma biomarker candidates of peritoneal endometriosis
11. Tea Lanišnik-Rižner, Trevor M. Penning: Aldo-keto reductase 1C3 - assessment as a new target for the treatment of endometriosis
12. Marko Hojnik, Nataša Kenda Šuster, Špela Smrkolj, Damjan Sisinger, Snježana Frković-Grazio, Ivan Verdenik, Tea Lanišnik-Rižner: AKR1B1 as a prognostic biomarker of high-grade serous ovarian cancer
13. Maša Sinreih, Klara Gregorič, Kristina Gajser, Tea Lanišnik-Rižner: Physiological concentrations of Cimicifuga racemosa extract do not affect expression of genes involved in estrogen biosynthesis and action in endometrial and ovarian cell lines
14. Luka Roškar, Irena Roškar, Tea Lanišnik-Rižner, Špela Smrkolj: Diagnostic and therapeutic values of angiogenic factors in endometrial cancer
15. Marko Hojnik, Nataša Kenda Šuster, Špela Smrkolj, Snježana Frković-Grazio, Ivan Verdenik, Tea Lanišnik-Rižner: AKR1C3 is associated with better survival of patients with endometrial carcinomas
16. Marko Hojnik, Snježana Frković-Grazio, Ivan Verdenik, Tea Lanišnik-Rižner: AKR1B1 and AKR1B10 as prognostic biomarkers of endometrioid endometrial carcinomas
17. Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier, Tea Lanišnik-Rižner: Aldo-keto reductases and cancer drug resistance
18. Jakob Kljun, Renata Pavlič, Eva Hafner, Tanja Lipec, Sara Moreno-Da Silva, Primož Tič, Iztok Turel, Tomaž Büdefeld, Jure Stojan, Tea Lanišnik-Rižner: Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
19. Vid Janša, Maja Pušić Novak, Helena Ban, Tea Lanišnik-Rižner: TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis
20. Vid Janša, Joško Osredkar, Ivan Verdenik, Tea Lanišnik-Rižner, Helena Ban: Oxidative stress markers cannot be used as endometriosis biomarkers in infertile patients
21. Alja Zottel, Rebeka Jójárt, Henrietta Ágoston, Eva Hafner, Neža Lipušček, Erzsébet Mernyák, Tea Lanišnik-Rižner: Cytotoxic effect of 13α-estrane derivatives on breast, endometrial and ovarian cancer cell lines
22. Tea Lanišnik-Rižner, Andrea Romano: Targeting the formation of estrogens for treatment of hormone dependent diseases–current status